This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Dexcom Inc, a leader in continuous glucose monitoring technology, officially opened its first manufacturing facility outside ...

In addition, you can check the fund’s top 5 holdings to determine its best picks for 2024. Aristotle Focus Growth Strategy ...

Shares of DexCom Inc. DXCM inched 0.44% higher to $68.91 Thursday, on what proved to be an all-around mixed trading session ...

Is the sky falling for DexCom (NASDAQ: DXCM)? Shares of the medical device specialist dropped off a cliff following its ...

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

US-based medical device firm Dexcom Inc has officially opened its new manufacturing facility in Batu Kawan, Penang, marking ...

David Padilla, 77, a Westbury resident, has been living with type 2 diabetes for over 40 years and continues to live life to ...

BofA raised the firm’s price target on DexCom (DXCM) to $90 from $80 and keeps a Buy rating on the shares post the Q3 report. DexCom did ...

DexCom's stock has declined 35% since my last bearish article, validating my "Sell" rating, though past bearish calls were incorrect as the stock previously doubled and tripled. Q3 results showed ...

DexCom (DXCM) reported $994.2 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 2%. EPS of $0.45 for the same period compares to $0.50 a year ago.